Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Pharmacological therapies did not differ significantly between patients with or without VC regarding iron supplementation, erythropoietin, laxatives, hypouricemic agents, statins, calcimimetics, calcium-based phosphate binders, non-calcium-based phosphate binders, and vitamin D.

Source: 3. Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Observational study.

Observational study

Observes exposures and outcomes without assigning the exposure; the subtype is not established here.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This cross-sectional observational study included 44 CKD patients undergoing peritoneal dialysis in Centro Hospitalar Universitário de São João in Porto, Portugal, between 2018 and 2019.

Source: Methods.

All participants were recruited voluntarily after receiving detailed information on the study protocol.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vascular Calcification and the Gut and Blood Microbiome in Chronic Kidney Disease Patients on Peritoneal Dialysis: A Pilot Study

Observational study · Biomolecules · 2022

Original publication title

Vascular Calcification and the Gut and Blood Microbiome in Chronic Kidney Disease Patients on Peritoneal Dialysis: A Pilot Study

Ana Merino-Ribas; Ricardo Araujo; Luciano Pereira; Joana Campos; Luísa Barreiros; Marcela A. Segundo; Nádia Silva; Carolina F. F. A. Costa; Janete Quelhas-Santos; Fábio Trindade; Inês Falcão-Pires; Ines Alencastre; Ioana Bancu Dumitrescu; Benedita Sampaio-Maia

© 2022 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Vascular calcification (VC) is a frequent condition in chronic kidney disease (CKD) and a well-established risk factor for the development of cardiovascular disease (CVD). Gut dysbiosis may contribute to CVD and inflammation in CKD patients. Nonetheless, the role of gut and blood microbiomes in CKD-associated VC remains unknown. Therefore, this pilot study aimed to explore the link between gut and blood microbiomes and VC in CKD patients on peritoneal dialysis (CKD-PD). Our results showed relative changes in specific taxa between CKD-PD patients with and without VC, namely Coprobacter, Coprococcus 3, Lactobacillus, and Eubacterium eligens group in the gut, and Cutibacterium, Pajaroellobacter, Devosia, Hyphomicrobium, and Pelomonas in the blood.

An association between VC and all-cause mortality risk in CKD-PD patients was also observed, and patients with higher mortality risk corroborate the changes of Eubacterium eligens in the gut and Devosia genus in the blood. Although we did not find differences in uremic toxins, intestinal translocation markers, and inflammatory parameters among CKD-PD patients with and without VC, soluble CD14 (sCD14), a nonspecific marker of monocyte activation, positively correlated with VC severity. Therefore, gut Eubacterium eligens group, blood Devosia, and circulating sCD14 should be further explored as biomarkers for VC, CVD, and mortality risk in CKD.

Authors’ abstract

Vascular calcification (VC) is a frequent condition in chronic kidney disease (CKD) and a well-established risk factor for the development of cardiovascular disease (CVD). Gut dysbiosis may contribute to CVD and inflammation in CKD patients. Nonetheless, the role of gut and blood microbiomes in CKD-associated VC remains unknown. Therefore, this pilot study aimed to explore the link between gut and blood microbiomes and VC in CKD patients on peritoneal dialysis (CKD-PD). Our results showed relative changes in specific taxa between CKD-PD patients with and without VC, namely Coprobacter, Coprococcus 3, Lactobacillus, and Eubacterium eligens group in the gut, and Cutibacterium, Pajaroellobacter, Devosia, Hyphomicrobium, and Pelomonas in the blood.

An association between VC and all-cause mortality risk in CKD-PD patients was also observed, and patients with higher mortality risk corroborate the changes of Eubacterium eligens in the gut and Devosia genus in the blood. Although we did not find differences in uremic toxins, intestinal translocation markers, and inflammatory parameters among CKD-PD patients with and without VC, soluble CD14 (sCD14), a nonspecific marker of monocyte activation, positively correlated with VC severity. Therefore, gut Eubacterium eligens group, blood Devosia, and circulating sCD14 should be further explored as biomarkers for VC, CVD, and mortality risk in CKD.

Publication and source details

Original title: Vascular Calcification and the Gut and Blood Microbiome in Chronic Kidney Disease Patients on Peritoneal Dialysis: A Pilot Study

Ana Merino-Ribas; Ricardo Araujo; Luciano Pereira; Joana Campos; Luísa Barreiros; Marcela A. Segundo; Nádia Silva; Carolina F. F. A. Costa; Janete Quelhas-Santos; Fábio Trindade; Inês Falcão-Pires; Ines Alencastre; Ioana Bancu Dumitrescu; Benedita Sampaio-Maia

Biomolecules · 2022

* Correspondence: bmaia@fmd.up.pt; Tel.: +351-220-901-100© 2022 by the authors.2022https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Competitiveness and Internationalization Operational Program (POCI)PORTUGAL 2020 Partnership AgreementEuropean Regional Development Fund (ERDF)FCT: Fundação para a Ciência e a TecnologiaPOCI-01-0145-FEDER-029777PTDC/MEC-MCI/29777/2017PT national funds (FCT/MCTES)UIDB/50006/2020FCT/MCTES scholarships2020.08540.BDIndividual Call to Scientific Employment Stimulus: Second EditionCEECIND/01070/2018FCT/MCTESDL 57/2016/CP1360/CT0007UnICUIDP/00051/2020This work is a result of the project POCI-01-0145-FEDER-029777 (PTDC/MEC-MCI/29777/2017), co-financed by Competitiveness and Internationalization Operational Program (POCI), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF) and through national funds by the FCT: Fundação para a Ciência e a Tecnologia. PT national funds (FCT/MCTES) also supported this work through grants UIDB/50006/2020. The Ph.D. fellowships of C.F.F.A.C. was supported by FCT/MCTES scholarships with the reference 2020.08540.BD. R.A. was supported by Individual Call to Scientific Employment Stimulus: Second Edition (grant number CEECIND/01070/2018). ISA was supported by FCT/MCTES contract DL 57/2016/CP1360/CT0007. F.T. is a recipient of a postdoctoral research grant by UnIC (UIDP/00051/2020).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T08:47:18.980746+00:00

DOI: 10.3390/biom12070867 · PMC9313079